Dr. John Kim John Kim provides a fantastic exposition on novel approaches to device development in managing #PF. Highlights the ideal device. Can these adjust for confounders? #PFF2023 Pulmonary Fibrosis Foundation

hope is not a strategy. With no new medicine there is no hope. Clinical trials important says pulmonary fibrosis patient advocate at Pulmonary Fibrosis Foundation national summit.

Patient Keith Boyle provides an inspiring talk on his journey with PF. Pulmonary Fibrosis Foundation #PFFSummit2023

An incredible story of strength and innovation from Shavini Fernando at the #PFFSummit2023 Pulmonary Fibrosis Foundation What a phenomenal story!

Dr. David Zhang David Zhang discusses novel and exciting research supporting the diagnostic utility of short telomeres in managing #PulmonaryFibrosis. #PFF2023 Pulmonary Fibrosis Foundation

Dr. Jeremy Katzen from Penn Medicine discusses lessons learned from the studies on the epithelial aspects of drug targeting in familial #pulmonaryfibrosis. Leveraging the creation of a transgenic mouse elucidated a surfactant mutation underpinning fibrosis. #PFF2023 Pulmonary Fibrosis Foundation

Excellent talk by Janet Talbert CGC from Vanderbilt University discussing when to get genetic testing in #PF. #PFF2023 Pulmonary Fibrosis Foundation

Our paper led by Michigan Medicine Pulmonary & Critical Care 🫁 David O'Dwyer is out in ATS Blue Journal examining oral microbiome and IPF in CleanUP-IPF clinical trial 👇 atsjournals.org/doi/abs/10.116…

How can we integrate guideline-defined radiologic patterns to diagnose interstitial lung disease,? Read the original research in the December issue: hubs.la/Q02cJrp90

Fantastic review on how to differentiate various patterns in patients with fibrotic lung diseases. journal.chestnet.org/article/S0012-…

Out this week: Delphi consensus study on different radiographic patterns of sarcoidosis Courtesy of Kerri Johannson MD MPH and Sujal Desai (and many others who don't have Twitter/X) thelancet.com/journals/lanre…

In ERJ this month, results of an inhaled recombinant GM-CSF study in patients with autoimmune PAP. TL;DR: resulted in better oxygenation and biomarkers, less need for whole lung lavage. erj.ersjournals.com/content/63/1/2…

How helpful is the 6 minute walk test for patients with ILD? Very helpful! New in CHEST this month by Mariana Hoffman and colleagues journal.chestnet.org/article/S0012-…

Substantial rates of silicosis in metal/non-metal miners located in Western U.S. states. Courtesy of investigators ColoradoSPH Environmental & Occupational Health atsjournals.org/doi/full/10.11…

We discuss some of the challenges in design of an AE-IPF trial in this protocol paper for STRIVE-IPF study - an area of unmet need in #curePF and important considerations when developing novel adaptive trial platforms REMAP-ILD bmcpulmmed.biomedcentral.com/articles/10.11…

Living in disadvantaged neighborhoods is associated with worse IPF survival. New in Annals of the ATS this month. atsjournals.org/doi/10.1513/An…

CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the April 2024 issue. Listen now: hubs.la/Q02r_6My0 #JournalCHEST #MedEd

The deadline to submit your preliminary topic proposals has been extended to Monday, April 15. Your idea could help create a high-quality guideline that will impact clinical practice. Share your input and expand your professional portfolio. Submit now: hubs.la/Q02r-lT00

Navigating disease progression in patients with combined COPD and pulmonary fibrosis is hard. Investigators find DLCO looks to be a better surrogate. erj.ersjournals.com/content/63/4/2…

Further insights on the pathophysiology of acute inflammatory lung injury related to vaping. atsjournals.org/doi/10.1164/rc…